Shares plunged nearly 30% as investors were disappointed by a revised downward revenue outlook driven by accelerated deceleration in BetterHelp’s cash pay users and network constraints limiting insurance growth.
Shares of Teladoc Health rose 8.6% post-earnings, with investor enthusiasm driven by top- and bottom-line results exceeding guidance and early traction in the shift of BetterHelp's model toward insurance coverage.